Selegilin

Were you looking for information about Selegiline? Selegilin is a common misspelling of selegiline.
 
Selegiline hydrochloride (Eldepryl®) is approved to treat the symptoms of Parkinson's disease. This prescription medication is only approved for use in combination with carbidopa-levodopa medications. As a monoamine oxidase inhibitor (MAOI), selegiline works to increase the levels of a certain brain chemical (dopamine). It is possible to take too much selegiline. Make sure to seek immediate medical attention if you think you may have overdosed on this medication. Some signs of a selegiline overdose can include hallucinations, seizures, and difficulty breathing.
 
(For the complete eMedTV article on this drug, click Selegiline. This article offers an in-depth look at how selegiline works to treat Parkinson's disease, and also offers tips on when and how to take the medication.)
 
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;